Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
08/2004
08/19/2004WO2004069197A2 Novel substituted 2,3-benzodiazepine derivatives
08/19/2004WO2004068946A2 Thiabendazole sorbate, method for the production thereof, and use thereof
08/19/2004WO2004056365A3 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
08/19/2004WO2004041201A3 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
08/19/2004WO2004037784A3 Pyrrolidones with anti-hiv activity
08/19/2004WO2004014902A8 Compounds having an activity at metabotropic glutamate receptors
08/19/2004WO2003094853A3 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
08/19/2004WO2003049702A8 Vanilloid receptor ligands and their use in treatments
08/19/2004US20040162427 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands
08/19/2004US20040162426 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease
08/19/2004US20040162331 Heterocylic amines used as antidiabetic or hyperglycemic agents
08/19/2004US20040162325 phenyloxazole- or thiazole-alkyl-1,3-dioxane or 1,3-dithiane derivatives; therapeutic drugs for lowering blood triglyceride, low-density lipoprotein cholesterol; arteriosclerosis, diabetes mellitus, hypertension, obesity
08/19/2004US20040162321 For therapy of disease characterized by inflammatory, allergic, or proliferative processes
08/19/2004US20040162319 For prophylaxis and therapy of thrombotic conditions including coronary artery and cerebrovascular diseases
08/19/2004US20040162318 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases
08/19/2004US20040162314 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents
08/19/2004US20040162290 For therapy of cancer, benign prostatic hypertrophy or myoma of the uterus, endometriosis, polycystic ovarian disease, uterine fibroids or precocious puberty, lupus erythematosis, irritable bowel syndrome, premenstrual syndrome, hirsutism
08/19/2004US20040162285 Anti-infective agents
08/19/2004US20040162283 Acyclic and cyclic guanidine-and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides
08/19/2004US20040162276 Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology
08/19/2004US20040161441 Containing permethrin, imidacloprid and n-methylpyrrolidone; killing ticks and fleas; skin friendly, low toxicity; storage stability
08/19/2004DE10305098A1 New effector conjugates of epithilones useful to treat e.g. diseases associated with proliferative processes, neurodegenerative diseases, multiple sclerosis, Alzheimer's disease and rheumatoid arthritis
08/19/2004DE10304870A1 Triazolverbindungen und ihre therapeutische Verwendung Triazole compounds and their therapeutic use
08/19/2004DE10237722A1 Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase Indole or benzimidazole derivatives for the modulation of IkappaB kinase
08/19/2004CA2515311A1 Antibacterial agents
08/19/2004CA2513529A1 Substituted heterocyclic compounds useful in the treatment of cardiovascular diseases
08/19/2004CA2512616A1 Novel substituted 2,3-benzodiazepine derivatives
08/18/2004EP1447405A1 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors
08/18/2004EP1447401A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
08/18/2004EP1447399A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses"
08/18/2004EP1446404A1 Rosiglitazone edisylates and their use as antidiabetics
08/18/2004EP1446403A1 Aryl substituted oxazolidinones with antibacterial activity
08/18/2004EP1446402A1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase
08/18/2004EP1446399A1 Piperazine derivatives having sst1 antagonistic activity
08/18/2004EP1446394A1 NOVEL 1,2,4−THIADIAZOLE DERIVATIVES AS MELANOCORTIN RECEPTOR MODULATORS
08/18/2004EP1446393A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
08/18/2004EP1446388A1 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
08/18/2004EP1446386A1 Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control
08/18/2004EP1446385A1 Preparation and use of substituted imidazoles
08/18/2004EP1446375A1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents
08/18/2004EP1446116A1 Inhibitors of dipeptidyl peptidase iv
08/18/2004EP1446110A2 Organosulfur inhibitors of tyrosine phosphatases
08/18/2004EP1294366B1 Pharmaceutical compounds for treating copd
08/18/2004EP1179343B1 Remedies for diabetes comprising 2-(n-cyanoimino)thiazolidine-4-one derivatives
08/18/2004EP0876345B1 Heterocyclic compounds as h+-atpases
08/18/2004CN1522253A Novel heterocyclic derivatives and medicinal use thereof
08/18/2004CN1522252A Dihydro-benzo(b)(1,4)diazepin-2-one derivatives as mglur2 antagonists I
08/18/2004CN1522251A Azole compounds, process for preparation of the same and use thereof
08/18/2004CN1522250A Cyclic diamine compound having five-membered cyclic group
08/18/2004CN1521258A Novel epothilones compound and its preparation method and application
08/18/2004CN1521165A Thiophene derivative
08/18/2004CN1162427C Amine derivatives compounds as medicament and its salts and esters used for medicine
08/18/2004CN1162425C 4-hydroxyl-piperidine derivative
08/18/2004CN1162412C Thiazylcinnamonitriles and pest controlling agents
08/18/2004CN1162152C Remedies for diabetes
08/17/2004US6777557 Method and composition for rejuvenating cells, tissues organs, hair and nails
08/17/2004US6777425 Which binds nucleic acids/dna; gene expression; genetic engineering
08/17/2004US6777422 Substituted tetrahydroisoquinolines as C5a receptor modulators
08/17/2004US6777412 Fungicides
08/12/2004WO2004067530A1 Isothiazole derivatives
08/12/2004WO2004067529A1 Indole-derivative modulators of steroid hormone nuclear receptors
08/12/2004WO2004067527A1 Thiophene derivatives as microbicides and herbicides
08/12/2004WO2004067521A1 Thiazole derivatives and their use as vap-1 inhibitors
08/12/2004WO2004067520A1 Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors
08/12/2004WO2004067506A2 Substituted heterocyclic compounds
08/12/2004WO2004066952A2 Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
08/12/2004WO2004056799A3 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
08/12/2004WO2004056347A3 Pharmaceutical compositions comprising insulin and legends of insulin hexamer
08/12/2004WO2004048368A3 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors
08/12/2004WO2004046120A3 Diaminotriazoles useful as inhibitors of protein kinases
08/12/2004WO2004039811A3 A method for manufacture of ceftiofur
08/12/2004WO2004015131A3 Hepatitis c virus assays
08/12/2004WO2003092374A3 Pesticidal heterocycles
08/12/2004US20040158076 Tyrosine derivatives
08/12/2004US20040158071 Novel benzylpiperidine compound
08/12/2004US20040158067 Binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology
08/12/2004US20040157909 Modulating protein kinase signal transduction; anticancer agents
08/12/2004US20040157900 Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus
08/12/2004US20040157897 Polymorphs of an epothilone analog
08/12/2004US20040157893 Pyrazole compounds useful as protein kinase inhibitors
08/12/2004US20040157892 Insecticides; miticides
08/12/2004US20040157886 Brain disorders; central nervous system disorders; viricides
08/12/2004US20040157885 PPAR activators
08/12/2004US20040157883 Imidazolamino compounds
08/12/2004US20040157866 Amide compounds
08/12/2004US20040157861 Compositions and methods for inhibiting TGF-beta
08/12/2004US20040157859 Pyrrolidones with anti-HIV activity
08/12/2004US20040157854 CCRS antagonists useful for treating aids
08/12/2004US20040157850 Novel heterocyclic derivatives
08/12/2004US20040157845 Vanilloid receptor ligands and their use in treatments
08/12/2004US20040157844 6-azauracil derivatives as thyroid receptor ligands
08/12/2004US20040157843 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase
08/12/2004US20040157829 useful in the treatment of central or peripheral nervous system disorders(e.g., migraine, ataxia, Parkinson's disease, bipolar disorders, epilepsy, hearing and vision loss, Alzheimer's disease, etc.) and as neuroprotective agent
08/12/2004US20040157827 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
08/12/2004US20040157822 Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1
08/12/2004US20040157801 Anti-sickling agents
08/12/2004US20040157264 Piperazine melanocortin-specific compounds
08/12/2004US20040156869 Also 2-substituted quinolines, isoquinolines, pyridoquinolines, pyridoisoquinolines, and pyridoquinazolines; treatment of conditions responsive to capsaicin receptor modulation, especially various kinds of pain
08/12/2004DE10255984A1 New 2-aminopyrimidine derivatives are cyclin-dependent kinase inhibitors useful for treating e.g. cancer, autoimmune diseases, cardiovascular diseases, infectious diseases or viral infections
08/12/2004CA2514573A1 Thiazole derivatives and their use as vap-1 inhibitors